Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco / Pavithra Viswanath, PhD |
Innovation Grants |
2024 |
California |
The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
Targeting of a putative unresolved wound healing process in childhood ependymoma |
University of Colorado Denver / Nicholas Foreman, MD |
Innovation Grants |
2024 |
Colorado |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
The influence of the raphe nucleus and serotonin on progression of diffuse intrinsic pontine glioma |
Stanford University / Richard Drexler, MD/PhD |
Young Investigator Grants |
2024 |
California |
Improving homing and activity of CAR T cells in pediatric sarcomas |
University of Colorado Denver / Joselyn Cruz Cruz, PhD |
Young Investigator Grants |
2024 |
Colorado |
Defining how unique properties of the pediatric immune system contribute to poor efficacy of checkpoint blockade in children |
Stanford University / Adrienne Long, MD/PhD |
Young Investigator Grants |
2024 |
California |
Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma |
University of Colorado Denver / Dong Wang, PhD |
Young Investigator Grants |
2024 |
Colorado |
Novel mechanisms and therapeutic targeting of chemoresistant rhabdomyosarcoma |
Massachusetts General Hospital / Yueyang Wang, PhD |
Young Investigator Grants |
2024 |
Massachusetts |